These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26324461)

  • 1. Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?
    Cannella L; Caocci G; Jacobs M; Vignetti M; Mandelli F; Efficace F
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):542-54. PubMed ID: 26324461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.
    Efficace F; Kemmler G; Vignetti M; Mandelli F; Molica S; Holzner B
    Eur J Cancer; 2008 Jul; 44(11):1497-506. PubMed ID: 18555682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement.
    Ziogas DC; Zintzaras E
    Ann Epidemiol; 2009 Jul; 19(7):494-500. PubMed ID: 19523596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia.
    Bryant AL; Drier SW; Lee S; Bennett AV
    Leuk Res; 2018 Jul; 70():106-116. PubMed ID: 29925044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes.
    Caocci G; La Nasa G; Efficace F
    Expert Rev Hematol; 2009 Feb; 2(1):69-80. PubMed ID: 21082996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
    Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
    Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
    Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
    J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times.
    Patel SS; Gerds AT
    Curr Hematol Malig Rep; 2017 Oct; 12(5):455-460. PubMed ID: 28822056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials.
    Giesinger JM; La Nasa G; Sparano F; Angermeyer M; Morelli E; Mulas O; Efficace F; Caocci G
    Clin Pract Epidemiol Ment Health; 2021; 17(1):307-314. PubMed ID: 35444708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health Span.
    Barot SV; Patel BJ; Gerds AT
    Curr Hematol Malig Rep; 2020 Apr; 15(2):149-154. PubMed ID: 32048198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.
    Lyman GH; Dale DC; Wolff DA; Culakova E; Poniewierski MS; Kuderer NM; Crawford J
    J Clin Oncol; 2010 Jun; 28(17):2914-24. PubMed ID: 20385991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
    Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome.
    Tambaro FP; Garcia-Manero G; O'Brien SM; Faderl SH; Ferrajoli A; Burger JA; Pierce S; Wang X; Do KA; Kantarjian HM; Keating MJ; Wierda WG
    Leukemia; 2016 Feb; 30(2):325-30. PubMed ID: 26290497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
    Klepin HD
    Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review.
    Rutherford C; King MT; Butow P; Legare F; Lyddiatt A; Souli I; Rincones O; Stacey D
    Qual Life Res; 2019 Mar; 28(3):593-607. PubMed ID: 30426276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advances of studies on the therapy-related myelodysplastic syndromes/acute myeloid leukemia].
    Li CJ; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1757-60. PubMed ID: 25543511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.
    Deschler B; de Witte T; Mertelsmann R; Lübbert M
    Haematologica; 2006 Nov; 91(11):1513-22. PubMed ID: 17082009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes in acute myeloid leukemia: Where are we now?
    Buckley SA; Kirtane K; Walter RB; Lee SJ; Lyman GH
    Blood Rev; 2018 Jan; 32(1):81-87. PubMed ID: 28888621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.